Kishimoto T - Search Results

1

Rapid improvement of AA amyloidosis with humanised anti-interleukin 6 receptor antibody treatment.

Nishida S, Hagihara K, Shima Y, Kawai M, Kuwahara Y, Arimitsu J, Hirano T, Narazaki M, Ogata A, Yoshizaki K, Kawase I, Kishimoto T, Tanaka T. Nishida S, et al. Among authors: kishimoto t. Ann Rheum Dis. 2009 Jul;68(7):1235-6. doi: 10.1136/ard.2008.099267. Ann Rheum Dis. 2009. PMID: 19525413 No abstract available.

2

Anti-interleukin 6 receptor antibody treatment in rheumatic disease.

Nishimoto N, Kishimoto T, Yoshizaki K. Nishimoto N, et al. Among authors: kishimoto t. Ann Rheum Dis. 2000 Nov;59 Suppl 1(Suppl 1):i21-7. doi: 10.1136/ard.59.suppl_1.i21. Ann Rheum Dis. 2000. PMID: 11053081 Free PMC article. Review.

3

Sustained response to tocilizumab, anti-interleukin-6 receptor antibody, in two patients with refractory relapsing polychondritis.

Kawai M, Hagihara K, Hirano T, Shima Y, Kuwahara Y, Arimitsu J, Narazaki M, Ogata A, Kawase I, Kishimoto T, Tanaka T. Kawai M, et al. Among authors: kishimoto t. Rheumatology (Oxford). 2009 Mar;48(3):318-9. doi: 10.1093/rheumatology/ken468. Epub 2008 Dec 23. Rheumatology (Oxford). 2009. PMID: 19106169 No abstract available.

4

Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy.

Nishimoto N, Sasai M, Shima Y, Nakagawa M, Matsumoto T, Shirai T, Kishimoto T, Yoshizaki K. Nishimoto N, et al. Among authors: kishimoto t. Blood. 2000 Jan 1;95(1):56-61. Blood. 2000. PMID: 10607684 Free article. Clinical Trial.

5

Molecular biology and immunology of interleukin-6.

Hirano T, Kishimoto T. Hirano T, et al. Among authors: kishimoto t. Res Immunol. 1992 Sep;143(7):723-4. doi: 10.1016/0923-2494(92)80010-i. Res Immunol. 1992. PMID: 1439144 No abstract available.

6

Myeloma cells express Fas antigen/APO-1 (CD95) but only some are sensitive to anti-Fas antibody resulting in apoptosis.

Shima Y, Nishimoto N, Ogata A, Fujii Y, Yoshizaki K, Kishimoto T. Shima Y, et al. Among authors: kishimoto t. Blood. 1995 Feb 1;85(3):757-64. Blood. 1995. PMID: 7530506 Free article.

7

Interleukin 6 and plasma cell neoplasias.

Hirano T, Kishimoto T. Hirano T, et al. Among authors: kishimoto t. Prog Growth Factor Res. 1989;1(3):133-42. doi: 10.1016/0955-2235(89)90007-0. Prog Growth Factor Res. 1989. PMID: 2491260 Review.

8

Therapy of rheumatoid arthritis by blocking IL-6 signal transduction with a humanized anti-IL-6 receptor antibody.

Yoshizaki K, Nishimoto N, Mihara M, Kishimoto T. Yoshizaki K, et al. Among authors: kishimoto t. Springer Semin Immunopathol. 1998;20(1-2):247-59. doi: 10.1007/BF00832010. Springer Semin Immunopathol. 1998. PMID: 9836380 Review. No abstract available.

9

Anticytokine therapy in autoimmune diseases.

Nishimoto N, Kishimoto T, Yoshizaki K. Nishimoto N, et al. Among authors: kishimoto t. Intern Med. 1999 Feb;38(2):178-82. doi: 10.2169/internalmedicine.38.178. Intern Med. 1999. PMID: 10225680 Free article. Review.

10

Interleukin-6: possible implications in human diseases.

Hirano T, Kishimoto T. Hirano T, et al. Among authors: kishimoto t. Ric Clin Lab. 1989 Jan-Mar;19(1):1-10. doi: 10.1007/BF02871787. Ric Clin Lab. 1989. PMID: 2669108 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,045 results

Search Page

Filters